Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
92.2M
-
Number of holders
-
115
-
Total 13F shares, excl. options
-
37M
-
Shares change
-
-3.62M
-
Total reported value, excl. options
-
$86.3M
-
Value change
-
-$6.94M
-
Put/Call ratio
-
2.21
-
Number of buys
-
37
-
Number of sells
-
-74
-
Price
-
$2.33
Significant Holders of Caribou Biosciences, Inc. - Common Stock (CRBU) as of Q3 2025
148 filings reported holding CRBU - Caribou Biosciences, Inc. - Common Stock as of Q3 2025.
Caribou Biosciences, Inc. - Common Stock (CRBU) has 115 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37M shares
of 92.2M outstanding shares and own 40.16% of the company stock.
Largest 10 shareholders include Pfizer Inc (4.69M shares), VANGUARD GROUP INC (4.23M shares), MILLENNIUM MANAGEMENT LLC (3.22M shares), Kynam Capital Management, LP (3.07M shares), BlackRock, Inc. (1.46M shares), Aberdeen Group plc (1.39M shares), PFM Health Sciences, LP (1.36M shares), TWO SIGMA ADVISERS, LP (1.23M shares), DIMENSIONAL FUND ADVISORS LP (1.21M shares), and BANK OF AMERICA CORP /DE/ (1.07M shares).
This table shows the top 115 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.